On September 20, 2021 Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, reported that the Company will present at the Cantor Fitzgerald Virtual Global Healthcare Conference (Press release, Lipocine, SEP 20, 2021, View Source [SID1234588051]). The conference will be held virtually. Presentation details are below.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cantor Fitzgerald Virtual Global Healthcare Conference September 27-30, 2021

Presentation time: September 30, 2021 starting at 1:20 p.m. EST
Webcast link: View Source

The webcast of this presentation will also be available on Lipocine’s corporate website under "Events and Presentations" in the Investors section or using the webcast link above. The webcast will be available on Lipocine’s website for 90 days.